These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


604 related items for PubMed ID: 18786076

  • 1. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S, Cropper L, Mostafa S, Turner J, Bailey G, Pugh-Clarke K.
    J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
    [Abstract] [Full Text] [Related]

  • 2. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G, Gârneata L, Capusa C, Ursea N.
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P, Rumyantsev V.
    Arzneimittelforschung; 2010 Jan; 60(6a):373-85. PubMed ID: 20648929
    [Abstract] [Full Text] [Related]

  • 4. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R, Kalantar-Zadeh K.
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [Abstract] [Full Text] [Related]

  • 5. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
    Bhandari S, Naudeer S.
    J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
    [Abstract] [Full Text] [Related]

  • 6. Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
    Ferrari P, Mallon D, Trinder D, Olynyk JK.
    Nephrology (Carlton); 2010 Apr; 15(3):344-9. PubMed ID: 20470305
    [Abstract] [Full Text] [Related]

  • 7. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

  • 8. Clinical review of the newer intravenous iron therapy options.
    Edwards JH.
    Nephrol Nurs J; 2003 Feb; 30(1):70-3. PubMed ID: 12674953
    [Abstract] [Full Text] [Related]

  • 9. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.
    Yagil Y.
    Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
    Charytan C, Levin N, Al-Saloum M, Hafeez T, Gagnon S, Van Wyck DB.
    Am J Kidney Dis; 2001 Feb; 37(2):300-7. PubMed ID: 11157370
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Feb; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 13. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK, Morgenstern T.
    Dtsch Med Wochenschr; 2004 Sep 03; 129(36):1849-53. PubMed ID: 15368155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
    Wikström B, Bhandari S, Barany P, Kalra PA, Ladefoged S, Wilske J, Thomsen LL.
    J Nephrol; 2011 Sep 03; 24(5):589-96. PubMed ID: 21240875
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.